Our Mastery
Testimonial
- "Amazing success ratio in such uncertain market and paid service is very affordable ...Good job done by your team...keep it up guys."
-Venkat (Chennai)
Party Plot Owner - "I am trading in stock market since last 8 years; I have subscribed services from many advisory companies. Conclusion is that no one can provide 100% accuracy in this NSE market. But accuracy of intraday tips from this firm is the highest among all share tips companies" Rahul Varma (Mumbai)
Owner of an Insurance Firm - "I have taken free trial of intraday tips for 2 days and 80% call is profitable. Then I have subscribed paid membership for trading advice and now I am quite satisfied with services. Important thing is do not think more; Just trade what you are suggested" -Kevin Patel (Ahmedabad)
BDM at IT Company - "Made Good Profit in the Intraday, Jackpot Calls, F&o Tips. Overall Service is very good. Especially I like your Fast tips Sms Service & Exit Call System. Your tips have very good performance." -Manoj Arora (Delhi)
CEO of Real Estate Company
Aarti Drugs Limited share price today (on 30 September 2023).
We Provide Best stock tips for Aarti Drugs Limited. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Aarti Drugs Limited with today performance in nse market. Contact Us for Jackpot Stock tips.
Get Free Stock Tips for Aarti Drugs Limited
NSE SYMBOL : AARTIDRUGS
DATE OF LISTING : 19/09/2003
FACE VALUE : 10
ISIN NO : INE767A01016
Live Chart For Stock Market Trading of AARTI DRUGS LTD.
"Aarti Drugs Limited engages in the manufacture and sale of bulk drugs and its intermediates in India and internationally. It offers various active pharmaceutical ingredients in the therapeutic categories, such as anti inflammatory, cardioprotectant, antidiarrhoeals/antiprotozoals, antifungals, antiarthritis/osteoporosis, antihistamine, antibiotic, antidiabetic, alzheimers treatment, antihypertensive, antiBPH, sedative, traquilizar, antipsychotic, and vitamins. The company also provides pharmaceutical
According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues increased with 38.52%, from INR 480.32 tens of millions to INR 665.36 tens of millions. Operating result increased from INR 60.41 tens of millions to INR 82.96 tens of millions which means 37.33% change. The results of the period decreased -0.04% reaching INR 22.46 tens of millions at the end of the period against INR 22.47 tens of millions last year. Return on equity (Net income/Total equity) went from 13.83% to 12.73%, the Return On Asset (Net income / Total Asset) went from 5.28% to 8.94% and the Net Profit Margin (Net Income/Net Sales) went from 4.68% to 3.38% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 42.29% compared to 166.03% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.79 to 0.97 when compared to the previous year.
Aarti Drugs (AARTIDR), a pharmaceutical company, manufactures and sells bulk drugs and specialty chemicals worldwide. Part of the USD 265 million Aarti group, the company was incorporated on Sept. 28, 1984 as a private limited company and went public on July 1, 1992. Chandrakant V. Gogri is the chairman, and the managing director is Prakash M. Patil. The company focuses on the anti-diarrhea, anti-inflammatory therapeutic groups. With eight manufacturing facilities in Tarapur and Sarigam, the company manufactures vitamins, anti-arthritis, anti-fungal, antibiotics, ACE inhibitors, anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs. It has products like Aceclofenac, Metronidazole, Ketoconazole, Ciprofloxacin HCl and Metformin HCl to name a few. The company has already commissioned and made operational its new multipurpose manufacturing facility strictly designed and built in accordance with USFDA requirements. The manufacturing-units of ADL are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all units with one already approved. ADL has developed a state-of-the-art R&D center in Turbhe, Mumbai. It also have two inbuilt supporting R&D centers within the manufacturing sites which all are well recognized by Department of Science and Industrial Research, Government of India. Suyash Laboratories is a subsidiary of the company. The company has a joint venture Huanggang Yinhe Aarti Pharmaceutical Company to sell its drug ingredients in China. The company is engaged in contract manufacturing and has developed anti-fouling agents. The company exports to more than 85 countries with clients like Sanofi?Aventis, Merck, ..etc. The registered office is at Plot No. N-198, MIDC, Tarapur, Pamtembhi village, Palghar taluka, Thane-401506, Maharashtra and corporate office at Mahendra Industrial Estate, Ground floor, Road No. 29, Plot No. 109-D, Sion (East), Mumbai-400022. Financials The company disclosed fall of 23.45% in standalone net profit on y-o-y basis to Rs 51.90 million, while total income dropped 9.62% y-o-y basis to Rs 1.08 billion for the quarter ended September 2010.
( Equity cash, Nse Fno, Jackpot Call, Sure Shot Call, BTST/STBT call )
Under one plan with Unbelievable lowest price
for free trial visit Share tips
Nse Listed Companies with Live Charts
with live charts starting with that Alphabet.)
| A | B | C | D | E | F | G | H | I | J |
| K | L | M | N | O | P | Q | R | S | T |
| U | V | W | X | Y | Z |
